Expression of Tie2/Tek in breast tumour vasculature provides a new marker for evaluation of tumour angiogenesis

British Journal of Cancer

Volumn 77, Issue 1, 1998, Pages 51-56

  Peters, K G ^a   Coogan, A ^a   Berry, D ^a   Marks, J ^a   Iglehart, J D ^a   Kontos, C D ^a   Rao, P ^a   Sankar, S ^a   Trogan, E ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Angiogenesis; Breast cancer; Endothelium; Receptor tyrosine kinase; Tie2 Tek

Indexed keywords

PROTEIN TYROSINE KINASE; TUMOR MARKER;

ADULT; AGED; ANGIOGENESIS; ARTICLE; BREAST LESION; BREAST TUMOR; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY INFILTRATE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TUMOR VASCULARIZATION; VASCULAR ENDOTHELIUM;

EID: 0031964710     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.8     Document Type: Article

References (44)

1. Axelsson K, Ljung B-ME, Moore DH, Thor AD, Chew KL, Edgerton SM, Smith HS and Mayall, BH (1995) Tumor angiogenesis as a prognostic assay for invasive ductal breast carcinoma. J Natl Cancer Inst 87: 997-1008
2. Borgstrom P, Hillan KJ, Sriramarao P and Ferrara N (1996) Complete inhibition of angiogenesis and growth of microtumors by anti-vascular endothelial growth factor neutralizing antibody: novel concepts of angiostatic therapy from intravital videomicroscopy. Cancer Res 56: 4032-4039
3. Bosari S, Lee AKC, DeLellis RA, Wiley BD, Heatley GJ and Silverman ML (1992) Microvessel quantitation and prognosis in invasive breast carcinoma. Human Pathology 23: 755-761
4. Brown LF, Berse B, Jackman RW, Tognazzi K, Guidi AJ, Dvorak HF, Senger DR, Connolly JL and Schnitt SJ (1995) Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer. Hum Pathol 26: 86-91
5. Craft PS and Harris AL (1994) Clinical prognostic significance of tumour angiogenesis. Annals of Oncology 5: 305-311
6. Dumont DJ, Gradwohl GJ, Fong GH, Auerbach R and Breitman ML (1992) The endothelial-specific receptor tyrosine kinase. TEK, is a member of a new subfamily of receptors. Oncogene 8: 1293-1302
7. Dumont DJ, Gradwohl G, Fong G-H, Puri MC, Gertsenstein M, Auerbach A and Breitman ML (1994) Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo. Genes & Development 8: 1897-1909
8. Dvorak HF, Sioussat TM, Brown LF, Berse B, Nagy JA, Sotrel A, Manseau EJ, Van De Water L and Senger DR (1991) Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: concentration in tumor blood vessels. J Exp Med 174: 1275-1278
9. Easty DJ, Herlyn M and Bennett DC (1995) Abnormal protein tyrosine kinase gene expression during melanoma progression and metastasis. Int J Cancer 60: 129-136
10. Folkman J (1995) Angiogenesis in cancer, vascular, rheumatoid, and other disease. Nature Medicine 1: 27-31
11. Folkman J and D'Amore PA (1996) Blood vessel formation: what is its molecular basis? Cell 87: 1153-1155
12. Fox SB, Gatter KC, Bicknell R, Going JJ, Stanton P, Cooke TG and Harris AL (1993) Relationship of endothelial cell proliferation to tumor vascularity in human breast cancer. Journal of Cancer Research 53: 4161-4163
13. Fox SB, Leek RD, Smith K, Hollyer J, Greenall M and Harris AL (1994) Tumor angiogenesis in node-negative breast carcinomas - relationship with epidermal growth factor receptor, estrogen receptor, and survival. Breast Cancer Research and Treatment 29: 109-116
14. Gasparini G, Weidner N, Bevilacqua P, Maluta S, Palma PD, Caffo O, Barbareschi M, Boracchi P, Marubini E and Pozza F (1994). Tumor microvessel density, p53 expression, tumor size and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma. J Clin Onc 12: 454-466
15. Goulding H, Rashid NF, Robertson JF, Bell JA, Elston CW, Blamey RW and Ellis IO (1995) Assessment of angiogenesis in breast carcinoma: an important factor in prognosis? Hum Pathol 26: 1196-1200
16. Hatva E, Kaipainen A, Mentula P, Jaaskelainen J, Paetau A, Haltia M and Alitalo K (1995) Expression of endothelial cell-specific receptor tyrosine kinases and growth factors in human brain tumors. Am J Path 146: 368-378
17. Hayes DF (1994) Angiogenesis and breast cancer. Breast Cancer 8: 51-71
18. Heimann R, Ferguson D, Powers C, Recant WM, Weichselbaum RR and Hellman S (1996) Angiogenesis as a predictor of long-term survival for patients with node-negative breast cancer. J Natl Cancer Inst 88: 1764-1769
19. Horak ER, Leek R, Klenk N, LeJeune S, Smith K, Stuart N, Greenall M, Stepniewska K and Harris AL (1992) Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. The Lancet 340: 1120-1124
20. Kaipainen A, Vlaykova T, Hatva E, Bohling T, Jekunen A, Pyrhonen S and Alitalo K (1994) Enhanced expression of the tie receptor tyrosine kinase mesenger RNA in the vascular endothelium of metastatic melanomas. Cancer Research 54: 6571-6577
21. Kim KJ, Li B, Winer J, Armanini M, Gillett N, Phillips HS and Ferrara N (1993) Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 362: 841-844
22. Korhonen J, Partanen J, Armstrong E, Vaahtokari A, Elenius K, Jalkanen M and Alitalo K (1992) Enhanced expression of the tie receptor tyrosine kinase in endothelial cells during neovascularization. Blood 80: 2548-2555
23. Maisonpierre PC, Goldfarb M, Yancopoulos GD and Gao G (1992) Distinct rat genes with related profiles of expression define a TIE receptor tyrosine kinase family. Oncogene 8: 1631-1638
24. Millauer B, Shawver LK, Plate KH, Risau W and Ullrich A (1994) Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Nature 367: 576-580
25. Millauer B, Longhi MP, Plate KH, Ahawver LK, Risau W, Ullrich A and Strawn LM (1996) Dominant-negative inhibition of flk-1 suppresses the growth of many tumor types in vivo. Cancer Research 56: 1615-1620
26. Mustonen T and Alitalo K (1995) Endothelial receptor tyrosine kinases involved in angiogenesis (Review). J Cell Biol 129: 895-898
27. Partanen J, Armstrong E, Makela TP, Korhonen J, Sandberg M, Renkonen R, Knuutila S, Huebner K and Alitalo K (1992) A novel endothelial cell surface receptor tyrosine kinase with extracellular epidermal growth factor homology domains. Mol Cell Biol 12: 1698-1707
28. Plate KH, Breier G and Risau W (1994a) Molecular mechanisms of developmental and tumor angiogenesis. Brain Pathology 4: 207-218
29. Plate KH, Breier G, Weich HA, Merinel HD and Risau W (1994b) Vascular endothelial growth factor and glioma angiogenesis: coordinate induction of VEGF receptors, distribution of VEGF protein and possible in vivo regulatory mechanisms. Int J Cancer 59: 520-529
30. Puri MC, Rossant J, Alitalo K, Bernstein A and Partanen J (1995) The receptor tyrosine kinase tie is required for integrity and survival of vascular endothelial cells. EMBO J 14: 5884-5891
31. Rak JW, St. Croix BD and Kerbel RS (1995) Consequences of angiogenesis for tumor progression, metastasis and cancer therapy. Anti-Cancer Drugs 6: 3-18
32. Salven P, Joensuu H, Heikkila P, Matikainen MT, Wasenius VM, Alanko A and Alitalo K (1996) Endothelial tie growth factor receptor provides antigenic marker for assessment of breast cancer angiogenesis. Br J Cancer 74: 69-72
33. Sato TN, Qin Y, Kozak CA and Audus KL (1993) tie-1 and tie-2 define another class of putative receptor tyrosine kinase genes expressed in early embryonic vascular system. Proc Natl Acad Sci USA 90: 9355-9358
34. Sato TN, Tozawa Y, Deutsch U, Wolburg-Buchholz K, Fujiwara Y, Gendron-Maguire M, Gridley T, Wolburg H, Risau W and Qin Y (1995) Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 376: 70-74
35. Senger DR, Brown LF, Claffey KP and Dvorak HF (1994) Vascular permeability factor, tumor angiogenesis and stroma generation. Invasion Metastasis 95: 385-394
36. Sütonen SM, Haapasalo HK, Rantala IS, Helin HJ and Isola JJ (1995) Comparison of different immunohistochemical methods in the assessment of angiogenesis: lack of prognostic value in a group of 77 selected non-negative breast carcinomas. Modern Pathology 8: 745-752
37. Suri C, Jones PF, Patan S, Bartunkova S, Maisonpierre PC, Davis S, Sato TN and Yancopoulos GD (1996) Requisite role of angiopoietin-1, a ligand for the Tie-2 receptor, during embryonic angiogenesis. Cell 87: 1171-1180
38. Takahashi Y, Kitadai Y, Bucana CD, Cleary KR and Ellis LM (1995) Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis and proliferation of human colon cancer. Cancer Research 55: 3964-3968
39. Toi M, Kashitani J and Tominaga T (1993) Tumor angiogenesis is an independent prognostic indicator in primary breast carcinoma. Int J Cancer 55: 371-374
40. Van Hoef ME, Knox WF and Dhesi, SS (1993) Assessment of tumour vascularity as a prognostic factor in lymph node negative invasive breast cancer. Eur J Cancer 29A: 1141-1145
41. Vikkula M, Boon LM, Carraway KL, Calvert JT, Diamonti AJ, Goumnerov B, Pasyk KA, Marchuk DA, Warman ML, Cantley LC, Mulliken JB and Olsen BR (1996) Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase Tie2. Cell 87: 1181-1190
42. Weidner N, Folkman J, Pozza F, Bevilacqua P, Allred E, Moore DH, Meli S and Gasparini G (1992) Tumor angiogenesis: a new significant and independent prognostic indicator in early state breast carcinoma. J Natl Cancer Inst 84: 1875-1887
43. Weidner N, Semple JP, Welch WR and Folkman J (1991) Tumor angiogenesis and metastasis correlation in invasive breast carcinoma. The New England Journal of Medicine 324: 1-8
44. Ziegler SF, Bird TA, Schneringer JA, Schooley KA and Baum PR (1992) Molecular cloning and characterization of a novel receptor protein tyrosine kinase from human placenta. Oncogene 8: 663-670